176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.55%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
3.51%
Positive gross profit growth while AMD is negative. John Neff would see a clear operational edge over the competitor.
5.06%
Positive EBIT growth while AMD is negative. John Neff might see a substantial edge in operational management.
5.06%
Positive operating income growth while AMD is negative. John Neff might view this as a competitive edge in operations.
16.13%
Positive net income growth while AMD is negative. John Neff might see a big relative performance advantage.
15.63%
Positive EPS growth while AMD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.00%
Positive diluted EPS growth while AMD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.18%
Share reduction more than 1.5x AMD's 4.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.19%
Diluted share reduction more than 1.5x AMD's 0.98%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-47.14%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-76.13%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
386.85%
10Y revenue/share CAGR above 1.5x AMD's 49.23%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
416.09%
Positive 5Y CAGR while AMD is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
21.27%
3Y revenue/share CAGR at 50-75% of AMD's 34.73%. Martin Whitman would question if the firm lags behind competitor innovations.
1047.86%
10Y OCF/share CAGR above 1.5x AMD's 579.21%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
200.98%
5Y OCF/share CAGR is similar to AMD's 190.99%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
6289.46%
3Y OCF/share CAGR above 1.5x AMD's 1190.42%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
637.92%
Net income/share CAGR above 1.5x AMD's 243.07% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
408.37%
5Y net income/share CAGR above 1.5x AMD's 248.85%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1184.03%
3Y net income/share CAGR above 1.5x AMD's 145.33%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
921.18%
10Y equity/share CAGR above 1.5x AMD's 30.80%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
846.67%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
30.11%
3Y equity/share CAGR at 50-75% of AMD's 51.90%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.23%
Our AR growth while AMD is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-2.21%
Inventory is declining while AMD stands at 20.19%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.70%
Asset growth above 1.5x AMD's 0.12%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.45%
Positive BV/share change while AMD is negative. John Neff sees a clear edge over a competitor losing equity.
-100.00%
We’re deleveraging while AMD stands at 5.16%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-0.12%
Our R&D shrinks while AMD invests at 5.49%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.54%
SG&A declining or stable vs. AMD's 20.89%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.